×

Subscribe Today

Get our free articles delivered directly to your email!

Continue reading

Contact Us
About Us
Subscribe
My Portfolio
My Account
Contact Us
About Us
Subscribe
My Account
My Portfolio
Logo

Insider Transactions by Greg Zante


Symbol CompanyOwnerRelationshipDateTransactionCost# SharesValue ($)Total SharesFiling
VKTXViking Therapeutics, Inc.Greg ZanteChief Financial OfficerJan 05, 2026Sale$32.9057,6611,896,969215,571Jan 05, 2026, 08:31 PM
VKTXViking Therapeutics, Inc.Greg ZanteChief Financial OfficerOct 28, 2025Sale$35.006,185216,481173,592Oct 28, 2025, 07:47 PM
VKTXViking Therapeutics, Inc.Greg ZanteChief Financial OfficerJul 03, 2025Sale$27.764,266118,428168,660Jul 03, 2025, 03:31 PM
VKTXViking Therapeutics, Inc.Greg ZanteChief Financial OfficerJan 06, 2025Sale$42.7550,3092,150,595169,959Jan 06, 2025, 08:14 PM
VKTXViking Therapeutics, Inc.Greg ZanteChief Financial OfficerOct 28, 2024Sale$76.61131,68710,089,164231,381Oct 28, 2024, 09:48 PM
VKTXViking Therapeutics, Inc.Greg ZanteChief Financial OfficerOct 28, 2024Option/RSU Exercise$7.4994,001704,282281,053Oct 28, 2024, 09:48 PM
VKTXViking Therapeutics, Inc.Greg ZanteChief Financial OfficerJul 30, 2024Sale$57.1516,136922,212190,526Jul 31, 2024, 04:05 PM
VKTXViking Therapeutics, Inc.Greg ZanteChief Financial OfficerMay 03, 2024Option/RSU Exercise$4.8634,249166,285241,610May 03, 2024, 08:51 PM
VKTXViking Therapeutics, Inc.Greg ZanteChief Financial OfficerMay 03, 2024Sale$74.6966,7564,986,008238,509May 03, 2024, 08:51 PM
VKTXViking Therapeutics, Inc.Greg ZanteChief Financial OfficerMar 27, 2024Tax Payment (Shares)$83.3416,6101,384,277207,361Mar 27, 2024, 08:50 PM
VKTXViking Therapeutics, Inc.Greg ZanteChief Financial OfficerMar 01, 2024Tax Payment (Shares)$85.2220,0931,712,325192,304Mar 04, 2024, 07:50 PM
VKTXViking Therapeutics, Inc.Greg ZanteChief Financial OfficerJan 03, 2024Tax Payment (Shares)$17.4049,122854,723209,602Jan 04, 2024, 09:35 PM
VKTXViking Therapeutics, Inc.Greg ZanteChief Financial OfficerJan 04, 2024Tax Payment (Shares)$18.5813,872257,742195,730Jan 04, 2024, 09:35 PM
VKTXViking Therapeutics, Inc.Greg ZanteChief Financial OfficerJan 04, 2024Sale$17.9015,000268,500180,730Jan 04, 2024, 09:35 PM
VKTXViking Therapeutics, Inc.Greg ZanteChief Financial OfficerApr 17, 2023Sale$20.007,500150,000149,279Apr 18, 2023, 07:07 PM
VKTXViking Therapeutics, Inc.Greg ZanteChief Financial OfficerApr 17, 2023Option/RSU Exercise$13.077,50098,025156,779Apr 18, 2023, 07:07 PM
VKTXViking Therapeutics, Inc.Greg ZanteChief Financial OfficerApr 11, 2023Option/RSU Exercise$5.2556,295295,778205,574Apr 13, 2023, 05:13 PM
VKTXViking Therapeutics, Inc.Greg ZanteChief Financial OfficerApr 11, 2023Sale$18.0056,2951,013,518149,279Apr 13, 2023, 05:13 PM
VKTXViking Therapeutics, Inc.Greg ZanteChief Financial OfficerApr 12, 2023Option/RSU Exercise$5.9941,544249,026190,823Apr 13, 2023, 05:13 PM
VKTXViking Therapeutics, Inc.Greg ZanteChief Financial OfficerApr 12, 2023Sale$18.0041,544747,792149,279Apr 13, 2023, 05:13 PM
VKTXViking Therapeutics, Inc.Greg ZanteChief Financial OfficerApr 03, 2023Sale$18.0030,911556,398147,778Apr 03, 2023, 07:24 PM
VKTXViking Therapeutics, Inc.Greg ZanteChief Financial OfficerMar 30, 2023Option/RSU Exercise$7.2993,750683,483278,807Apr 03, 2023, 07:24 PM
VKTXViking Therapeutics, Inc.Greg ZanteChief Financial OfficerMar 30, 2023Sale$17.00131,0292,227,821147,778Apr 03, 2023, 07:24 PM
VKTXViking Therapeutics, Inc.Greg ZanteChief Financial OfficerApr 03, 2023Tax Payment (Shares)$17.5755,166969,267149,279Apr 03, 2023, 07:24 PM
VKTXViking Therapeutics, Inc.Greg ZanteChief Financial OfficerApr 03, 2023Option/RSU Exercise$7.7730,911240,178178,689Apr 03, 2023, 07:24 PM
VKTXViking Therapeutics, Inc.Greg ZanteChief Financial OfficerJan 04, 2023Tax Payment (Shares)$8.4220,708174,361185,057Jan 04, 2023, 06:25 PM
VKTXViking Therapeutics, Inc.Greg ZanteChief Financial OfficerDec 30, 2022Tax Payment (Shares)$9.4019,697185,152139,031Jan 04, 2023, 06:25 PM
VKTXViking Therapeutics, Inc.Greg ZanteChief Financial OfficerJan 03, 2023Tax Payment (Shares)$8.5223,933203,909205,765Jan 04, 2023, 06:25 PM
VKTXViking Therapeutics, Inc.Greg ZanteChief Financial OfficerJan 03, 2022Tax Payment (Shares)$4.883,09715,11391,806Jan 05, 2022, 07:13 PM
VKTXViking Therapeutics, Inc.Greg ZanteChief Financial OfficerJan 04, 2022Tax Payment (Shares)$4.628,83540,818136,304Jan 05, 2022, 07:13 PM
VKTXViking Therapeutics, Inc.Greg ZanteChief Financial OfficerSep 28, 2021Tax Payment (Shares)$6.502,30614,98994,485Sep 30, 2021, 05:43 PM
VKTXViking Therapeutics, Inc.Greg ZanteChief Financial OfficerJan 19, 2021Tax Payment (Shares)$6.688085,39789,751Jan 19, 2021, 06:25 PM
VKTXViking Therapeutics, Inc.Greg ZanteChief Financial OfficerJan 04, 2021Tax Payment (Shares)$5.802,78716,16590,559Jan 06, 2021, 04:28 PM

Looking for more premium content?

We have created a comprehensive group of tools that allows you to estimate the intrinsic value of investments.

Subscribe